Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Caelyx pegylated liposomal

Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10–11

HOS-085574 · Präparat HOS-083155

10  Legionella, Microsporidium, Salmonella, Staphylococcus, Toxoplasma, Tuberculosis)a Neoplasms benign, Not known Acute myeloid leukaemiab malignant and Myelodysplastic syndromeb unspecified (including Oral neoplasmb cysts and polyps) Blood and lymphatic Very common Leukopaenia system disorders Neutropaenia Lymphopaenia Anaemia (including hypochromic) Common Thrombocytopaenia Febrile neutropaenia Uncommon Pancytopaenia Thrombocytosis Rare Bone marrow failure Immune system Uncommon Hypersensitivity disorders Anaphylactic reaction Rare Anaphylactoid reaction Metabolism and Very common Decreased appetite nutrition disorders Common Cachexia Dehydration Hypokalaemia Hyponatraemia Hypocalcaemia Uncommon Hyperkalaemia Hypomagnesaemia Psychiatric disorders Common Confusional state Anxiety Depression Insomnia Nervous system Common Neuropathy peripheral disorders Peripheral sensory neuropathy Neuralgia Paraesthesia Hypoaesthesia Dysgeusia Headache Lethargy Dizziness Uncommon Polyneuropathy Convulsion Syncope Dysaesthesia Somnolence Eye disorders Common Conjunctivitis Uncommon Vision blurred Lacrimation increased Rare Retinitis Cardiac disordersa Common Tachycardia Uncommon Palpitations Cardiac arrest Cardiac failure Cardiac failure congestive Cardiomyopathy

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.